POINT MUTATIONS OF RAS AND GSA SUBUNIT GENES IN THYROID-TUMORS

被引:27
作者
HORIE, H [1 ]
YOKOGOSHI, Y [1 ]
TSUYUGUCHI, M [1 ]
SAITO, S [1 ]
机构
[1] TOKUSHIMA MUNICIPAL HOSP, DEPT SURG, TOKUSHIMA 770, JAPAN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1995年 / 86卷 / 08期
关键词
GS-ALPHA; GI2-ALPHA; RAS; THYROID TUMOR;
D O I
10.1111/j.1349-7006.1995.tb02462.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We studied 43 thyroid tumors including 5 adenomatous goiters, 7 follicular adenomas, 22 papillary carcinomas, and 9 medullary carcinomas with regard to the presence of point mutations in the genes of Gs alpha subunit (Gs alpha), Gi2 alpha subunit (Gi2 alpha), H-ras, K-ras, and N-ras by a polymerase chain reaction-direct sequencing method. An adenomatous goiter and a follicular adenoma showed double mutations at codon 227 and 231, and 4 papillary carcinomas showed mutation at codon 231 of the Gs alpha gene. An adenomatous goiter, a follicular adenoma, and a papillary carcinoma showed a missense mutation in codon 13 of the K-ras gene. There were no such missense mutations of these G-protein or ras genes in medullary carcinomas. These data indicate that the genetic events involved in the oncogenesis of parafollicular C-cells are different from those of thyroid follicular cells, in which missense mutations of Gs alpha and ras genes seem to play important roles in tumorigenesis.
引用
收藏
页码:737 / 742
页数:6
相关论文
共 42 条
[1]  
BELFIORE A, 1987, CANCER, V60, P3096, DOI 10.1002/1097-0142(19871215)60:12<3096::AID-CNCR2820601240>3.0.CO
[2]  
2-V
[3]   SIGNAL-TRANSDUCTION VIA THE MAP KINASES - PROCEED AT YOUR OWN RSK [J].
BLENIS, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5889-5892
[4]  
BONGARZONE I, 1989, ONCOGENE, V4, P1457
[5]   RAS-DEPENDENT ACTIVATION OF MAP KINASE PATHWAY MEDIATED BY G-PROTEIN BETA-GAMMA-SUBUNITS [J].
CRESPO, P ;
XU, NZ ;
SIMONDS, WF ;
GUTKIND, JS .
NATURE, 1994, 369 (6479) :418-420
[6]   HYPERTHYROIDISM AND THYROID-CANCER [J].
EDMONDS, CJ ;
TELLEZ, M .
CLINICAL ENDOCRINOLOGY, 1988, 28 (02) :253-259
[8]   HIGH PREVALENCE OF MUTATIONS OF THE P53 GENE IN POORLY DIFFERENTIATED HUMAN THYROID CARCINOMAS [J].
FAGIN, JA ;
MATSUO, K ;
KARMAKAR, A ;
CHEN, DL ;
TANG, SH ;
KOEFFLER, HP .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :179-184
[9]   ONCOGENES AND GROWTH-FACTORS IN THYROID CARCINOGENESIS [J].
FRAUMAN, AG ;
MOSES, AC .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1990, 19 (03) :479-493
[10]   MUTATIONAL ACTIVATION OF RAS AND GSP ONCOGENES IN DIFFERENTIATED THYROID-CANCER AND THEIR BIOLOGICAL IMPLICATIONS [J].
GORETZKI, PE ;
LYONS, J ;
STACYPHIPPS, S ;
ROSENAU, W ;
DEMEURE, M ;
CLARK, OH ;
MCCORMICK, F ;
ROHER, HD ;
BOURNE, HR .
WORLD JOURNAL OF SURGERY, 1992, 16 (04) :576-582